CoChat
Sign Up
Cited by 77

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease

Sun, Sifan, Han, Xiaojuan, Li, Xueting, Song, Qiqi, Lu, Ming, Jia, Miaomiao, Ding, Jianhua, Hu, Gang·2018·Frontiers in Molecular Neuroscience
DOI 10.3389/fnmol.2018.00381PMC PMC6193094
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnmol.2018.00381

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 6 references

Research works printed but not linked: 42

  1. Akbulut, 2015, The role of melatonin, sirtuin2 and FoXO1 transcription factor in the aging process of colon in male rats., Biogerontology, 16, 99, 10.1007/s10522-014-9540-1 · DOI
  2. Beirowski, 2011, Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling., Proc. Natl. Acad. Sci. U.S.A., 108, E952, 10.1073/pnas.1104969108 · DOI
  3. Chen, 2015, The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia., PLoS One, 10, 10.1371/journal.pone.0116919 · DOI
  4. Cui, 2014, Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach., J. Med. Chem., 57, 8340, 10.1021/jm500777s · DOI
  5. de Oliveira, 2017, The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease., PLoS Biol., 15, 10.1371/journal.pbio.2000374 · DOI
  6. Dexter, 2013, Parkinson disease: from pathology to molecular disease mechanisms., Free Radic. Biol. Med., 62, 132, 10.1016/j.freeradbiomed.2013.01.018 · DOI
  7. Dix, 2017, Specific and novel microRNAs are regulated as response to fungal infection in human dendritic cells., Front. Microbiol., 8, 10.3389/fmicb.2017.00270 · DOI
  8. Donmez, 2012, The neurobiology of sirtuins and their role in neurodegeneration., Trends Pharmacol. Sci., 33, 494, 10.1016/j.tips.2012.05.007 · DOI
  9. Donmez, 2012, SIRT1 protects against alpha-synuclein aggregation by activating molecular chaperones., J. Neurosci., 32, 124, 10.1523/JNEUROSCI.3442-11.2012 · DOI
  10. Doxakis, 2010, Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153., J. Biol. Chem., 285, 12726, 10.1074/jbc.M109.086827 · DOI · Paper page
  11. Duan, 2013, Sirtuins: from metabolic regulation to brain aging., Front. Aging Neurosci., 5, 10.3389/fnagi.2013.00036 · DOI
  12. Fan, 2016, MicroRNA-7 enhances subventricular zone neurogenesis by inhibiting nlrp3/caspase-1 axis in adult neural stem cells., Mol. Neurobiol., 53, 7057, 10.1007/s12035-015-9620-5 · DOI · Paper page
  13. Gal, 2012, SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition., Neurochem. Int., 61, 992, 10.1016/j.neuint.2012.07.010 · DOI
  14. Han, 2018, Plin4-Dependent lipid droplets hamper neuronal mitophagy in the MPTP/p-induced mouse model of Parkinson’s disease., Front. Neurosci., 12, 10.3389/fnins.2018.00397 · DOI · Paper page
  15. Herskovits, 2014, SIRT1 in neurodevelopment and brain senescence., Neuron, 81, 471, 10.1016/j.neuron.2014.01.028 · DOI
  16. Jesko, 2017, Sirtuins and their roles in brain aging and neurodegenerative disorders., Neurochem. Res., 42, 876, 10.1007/s11064-016-2110-y · DOI
  17. Junn, 2012, MicroRNAs in neurodegenerative diseases and their therapeutic potential., Pharmacol. Ther., 133, 142, 10.1016/j.pharmthera.2011.10.002 · DOI · Paper page
  18. Kida, 2016, Sirtuins, Cell Senescence, and Vascular Aging., Can. J. Cardiol., 32, 634, 10.1016/j.cjca.2015.11.022 · DOI
  19. Lanford, 2010, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection., Science, 327, 198, 10.1126/science.1178178 · DOI · Paper page
  20. Lee, 2015, Sirtuin 1 (SIRT1) deacetylase activity and NAD(+)/NADH ratio are imperative for capsaicin-mediated programmed cell death., J. Agric. Food Chem., 63, 7361, 10.1021/acs.jafc.5b02876 · DOI
  21. Levine, 2008, p53: the Janus of autophagy?, Nat. Cell Biol., 10, 637, 10.1038/ncb0608-637 · DOI
  22. Li, 2013, Poly(ADP-ribose) polymerase mediates both cell death and ATP decreases in SIRT2 inhibitor AGK2-treated microglial BV2 cells., Neurosci. Lett., 544, 36, 10.1016/j.neulet.2013.03.032 · DOI
  23. Liu, 2014, SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway., Front. Aging Neurosci., 6, 10.3389/fnagi.2014.00184 · DOI
  24. Ma, 2013, Advances with microRNAs in Parkinson’s disease research., Drug Des. Dev. Ther., 7, 1103, 10.2147/DDDT.S48500 · DOI
  25. Maciotta, 2013, The involvement of microRNAs in neurodegenerative diseases., Front. Cell Neurosci., 7, 10.3389/fncel.2013.00265 · DOI
  26. Martinez-Vicente, 2015, Autophagy in neurodegenerative diseases: from pathogenic dysfunction to therapeutic modulation., Semin. Cell Dev. Biol., 40, 115, 10.1016/j.semcdb.2015.03.005 · DOI
  27. Maxwell, 2011, The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS., Hum. Mol. Genet., 20, 3986, 10.1093/hmg/ddr326 · DOI
  28. North, 2003, The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase., Mol. Cell, 11, 437, 10.1016/S1097-2765(03)00038-8 · DOI
  29. Outeiro, 2007, Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease., Science, 317, 516, 10.1126/science.1143780 · DOI
  30. Pais, 2013, The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation., EMBO J., 32, 2603, 10.1038/emboj.2013.200 · DOI
  31. Qiu, 2014, Deciphering the function and regulation of microRNAs in Alzheimer’s disease and Parkinson’s disease., ACS Chem. Neurosci., 5, 884, 10.1021/cn500149w · DOI
  32. Rumpf, 2015, Selective Sirt2 inhibition by ligand-induced rearrangement of the active site., Nat. Commun., 6, 10.1038/ncomms7263 · DOI
  33. Savitt, 2006, Diagnosis and treatment of Parkinson disease: molecules to medicine., J. Clin. Invest., 116, 1744, 10.1172/JCI29178 · DOI
  34. Shan, 2016, Fluoxetine protects against IL-1beta-induced neuronal apoptosis via downregulation of p53., Neuropharmacology, 107, 68, 10.1016/j.neuropharm.2016.03.019 · DOI
  35. van Leeuwen, 2013, Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2., Mol. Cancer Ther., 12, 471, 10.1158/1535-7163.MCT-12-0904 · DOI
  36. Venderova, 2012, Programmed cell death in Parkinson’s disease., Cold Spring Harb. Perspect. Med., 2, 10.1101/cshperspect.a009365 · DOI
  37. Wang, 2007, SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction., Aging Cell, 6, 505, 10.1111/j.1474-9726.2007.00304.x · DOI
  38. Ye, 2013, Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway., Neurosci. Lett., 553, 72, 10.1016/j.neulet.2013.08.020 · DOI
  39. Yu, 2009, The role of sirtuins in the control of metabolic homeostasis., Ann. N. Y. Acad. Sci., 1173, E10, 10.1111/j.1749-6632.2009.04952.x · DOI · Paper page
  40. Zhao, 2010, Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity., Nat. Cell Biol., 12, 665, 10.1038/ncb2069 · DOI
  41. Zhou, 2016, MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease., Mol. Neurodegener., 11, 10.1186/s13024-016-0094-3 · DOI · Paper page
  42. Zi, 2015, Circulating microRNA as potential source for neurodegenerative diseases biomarkers., Mol. Neurobiol., 52, 1494, 10.1007/s12035-014-8944-x · DOI

Cited by

Sorted by citations

See all 77

Metadata

Authors
Sun, S., Han, X., Li, X., Song, Q., Lu, M., Jia, M., Ding, J., & Hu, G.
Venue
Frontiers in Molecular Neuroscience
Publisher
Frontiers Media SA
Published
2018-10-11
Volume
11
ISSN
1662-5099
DOI
10.3389/fnmol.2018.00381
PMC
PMC6193094
Cited by
77
References
6
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)
Funders
National Natural Science Foundation of China (No. 81603091)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review